Vaccine News and Research

Latest Vaccine News and Research

Study shows mRNA booster dose eliminates immune escape observed with SARS-CoV-2 Omicron

Researchers examined total and neutralizing antibodies to the spike protein of SARS-CoV-2, and neutralizing antibodies against Washington-1 (WA-1) and variants of concern (VOC) including Beta, Delta, and Omicron in a longitudinal cohort.

31 Jan 2022

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

A new study has assessed the antibody responses to the mRNA-1273 Moderna vaccine over time.

31 Jan 2022

Study highlights importance of immunizing and boosting PAD syndromes patients with SARS-CoV-2 mRNA vaccines

A new study posted to the medRxiv* preprint server has evaluated the effect of mRNA-based COVID-19 vaccination and boosting strategy on serum antibody responses in PAD patients against the original SARS-CoV-2 strain and circulating variants.

31 Jan 2022

Preliminary study assesses durability of NAb titers against Omicron after mRNA-1273 booster

Researchers from Moderna, the developers of one key vaccine, have been investigating its ability to protect against the Omicron variant.

31 Jan 2022

Vaccination as a condition of deployment for health, social care staff revisited as Omicron replaces Delta

Regulations making vaccines a condition of deployment for health and social care staff are set to be revoked, subject to public consultation and parliamentary approval, the Health and Social Care Secretary has announced.

31 Jan 2022

BA.2 sublineage of Omicron shows increased immune evasion and transmission

Recently, researchers from the University of Copenhagen have been investigating the spread of two sublineages of the Omicron variant among Danish households.

31 Jan 2022

Response to COVID-19 vaccine booster in seronegative kidney transplant recipients

Modification of vaccination strategies is needed to improve the immune response to SARS-CoV-2 vaccination in kidney transplant recipients (KTRs).

31 Jan 2022

Yellow fever vaccine-vectored YF-S0 as a potent COVID-19 vaccine candidate

In a new study, a team of researchers developed YF-S0, an exceptionally potent COVID-19 vaccine candidate using live-attenuated yellow fever vaccine YF17D as a vector.

31 Jan 2022

Study assesses the antibody response to additional dose of COVID-19 vaccine in transplant recipients

A study has begun to assess the antibody response to an additional dose of a COVID-19 mRNA vaccine in kidney and liver transplant recipients, either alone or with a concurrent reduction in immunosuppressive medication.

31 Jan 2022

Armed Forces providing support within all four nations of the UK to overcome the pandemic

With the deployment of defense medics to hospitals in Northern Ireland, the Armed Forces are now providing support within all four nations of the United Kingdom as part of Operation Rescript.

31 Jan 2022

Three exposures to SARS-CoV-2 spike protein can induce robust neutralizing antibodies against variants

In a new study, scientists revealed that three consecutive exposures SARS-CoV-2 spike protein through infection, vaccination, or both can induce strong neutralizing antibodies against a wide variety of viral variants, including omicron.

31 Jan 2022

How many lives would vaccine sharing have saved?

In a new study, researchers have been investigating different COVID-19 vaccine sharing simulations, and how they would affect affect global mortality.

31 Jan 2022

It’s Day 6 of covid, and a rapid antigen test comes back positive. stay home, say virologists.

What does it mean if a person's rapid antigen test result comes back positive after five days of isolation due to covid-19? According to the experts, that person is most likely still carrying a viral load high enough to infect others.

31 Jan 2022

In California nursing homes, omicron is bad, but so is the isolation

Dina Halperin had been cooped up alone for three weeks in her nursing home room after her two unvaccinated roommates were moved out at the onset of the omicron surge. "I'm frustrated," she said, "and so many of the nursing staff are burned out or just plain tired."

31 Jan 2022

Study finds adults with disabilities have worse outcomes when hospitalized with COVID-19

Adults with disabilities have worse outcomes when hospitalized with COVID-19 than patients without disabilities, including longer hospital stays and increased risk of readmission, found new research in CMAJ

31 Jan 2022

Evaluating clinical outcomes and viral loads of SARS-CoV-2 Delta and Omicron infections

The current study showed a marked decrease in disease severity with Omicron compared to the Delta variant.

31 Jan 2022

Protection provided to children through parental vaccination with the BNT162b2 vaccine

In a new study published in Science, scientists estimated the protection provided to children by means of parental vaccination with the BNT162b2 vaccine.

31 Jan 2022

Vaccine hypersensitivity in children

A new paper published in Pediatric Allergy and Immunity provides a useful overview of such reactions in relation to pediatric vaccines.

31 Jan 2022

Binding and conformational properties of the SARS-CoV spike protein and hACE2 complex

A new paper in the journal Molecules describes this in molecular terms, comparing SARS-CoV-2 with an earlier highly pathogenic coronavirus, SARS-CoV.

31 Jan 2022

Vaccine-induced immunological memory is similar for Omicron and Delta SARS-CoV-2 variants

A new study by Norwegian researchers suggests that vaccine-induced immunological memory and the activation of recall responses in the body yields similar coverage for Omicron and Delta variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The paper is currently available on the medRxiv* preprint server while it undergoes peer review.

31 Jan 2022

Vaccine News and Research

Latest Vaccine News and Research

Study shows mRNA booster dose eliminates immune escape observed with SARS-CoV-2 Omicron

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Study highlights importance of immunizing and boosting PAD syndromes patients with SARS-CoV-2 mRNA vaccines

Preliminary study assesses durability of NAb titers against Omicron after mRNA-1273 booster

Vaccination as a condition of deployment for health, social care staff revisited as Omicron replaces Delta

BA.2 sublineage of Omicron shows increased immune evasion and transmission

Response to COVID-19 vaccine booster in seronegative kidney transplant recipients

Yellow fever vaccine-vectored YF-S0 as a potent COVID-19 vaccine candidate

Study assesses the antibody response to additional dose of COVID-19 vaccine in transplant recipients

Armed Forces providing support within all four nations of the UK to overcome the pandemic

Three exposures to SARS-CoV-2 spike protein can induce robust neutralizing antibodies against variants

How many lives would vaccine sharing have saved?

It’s Day 6 of covid, and a rapid antigen test comes back positive. stay home, say virologists.

In California nursing homes, omicron is bad, but so is the isolation

Study finds adults with disabilities have worse outcomes when hospitalized with COVID-19

Evaluating clinical outcomes and viral loads of SARS-CoV-2 Delta and Omicron infections

Protection provided to children through parental vaccination with the BNT162b2 vaccine

Vaccine hypersensitivity in children

Binding and conformational properties of the SARS-CoV spike protein and hACE2 complex

Vaccine-induced immunological memory is similar for Omicron and Delta SARS-CoV-2 variants

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in